This book offers a concise and updated guide for all readers (physicians and non-physicians) interested in gaining a comprehensive and precise understanding of sarcopenia.

Over the last several years, sarcopenia has increasingly developed from being a concept known only in research settings to one that is commonly explored in journals and scientific meetings for various disciplines, such as geriatrics, rheumatology and rehabilitation medicine. Thus, all domains of sarcopenia, from molecular aspects to clinical management, represent highly active areas of research and clinical practice for health professionals in a variety of fields, including geriatric medicine, nutrition, and epidemiology. Despite being a relatively new concept in medicine, sarcopenia is increasingly being recognized as an important determinant of other health conditions, including mortality and disability. This book, written by experts from around the globe, covers several core aspects of sarcopeniamanagement, from molecular mechanisms to genetics, epidemiology, diagnosis and finally treatment, including the clinical impact of sarcopenia as a risk factor, the known genetic and molecular aspects that can aid in predicting sarcopenia, and selected treatment and therapy concepts, including indications for nutrition and physical exercise. Sharing data from the latest studies, it will be of considerable interest not only for geriatricians, but also for a wide range of other readers.

Written by respected experts from around the globe Covers the most important diagnostic, clinical and treatment aspects of sarcopenia Offers a valuable guide for all readers interested in sarcopenia, addressing both clinical and research aspects

Autorentext

Nicola Veronese is a certified trained geriatrician, currently working as Senior Researcher in Geriatrics at the University of Palermo, Italy. His research is mainly epidemiological and focused on the most common diseases affecting older people. In particular, his interest areas are osteoarticular, metabolic (including obesity and diabetes) and cardiovascular diseases, as well as nutrition. He is the author of more than 350 articles published in national and international scientific journals, and of numerous abstracts accepted by national and international congresses.

Charlotte Beaudart works at the Department of Public Health, Epidemiology and Health Economics of the University of Liège, Belgium. She obtained her PhD in Public Health, Epidemiology and Health Economics in the University of Liège, Belgium in 2016. She obtained an FNRS fellowship for her doctoral research. It is in this context that she has obtained various awards and scholarships from the Belgian Bone Club, the Leon Frédéric Fund and the IOF (International Osteoporosis Foundation). In 2018, she received the prestigious ESCEO-IOF-Herbert Fleisch Medal.

Shaun Sabico completed his medical training at the University of Santo Tomas, Philippines and obtained his PhD in medical sciences (2018) from Warwick Medical School, Warwick University, UK. He works as the Deputy Director and Assistant Professor at the Chair for Biomarkers of Chronic Diseases, Biochemistry Department at King Saud University, Saudi Arabia. He has authored almost 200 scientific papers/abstracts published in reputable journals and has received numerous honors from international scientific conferences, including the Young Investigator Award from the World Congress of Osteoporosis, which he won twice: in Italy (2017) and in Poland (2018). He is the 2019 recipient of the International Osteoporosis Foundation's prestigious Pierre Meunier Young Scientist Award.

Inhalt
Chapter 1) Epidemiology of Sarcopenia.- Chapter 2) Definitions of Sarcopenia Across the World.- Chapter 3) Consequences of Sarcopenia in Older People: The Epidemiological Evidence.- Chapter 4) Emerging Markers for Sarcopenia.- Chapter 5) Screening for Sarcopenia.- Chapter 6) Radiological Evaluation of Muscle Mass.- Chapter 7) Physical Performance and Muscle Strength Tests: Pros and Cons.- Chapter 8) Is Sarcopenia a Condition, a Disorder, a Disease, or a True Geriatric Syndrome?.- Chapter 9) Sarcopenia in Other Settings: Primary Care, Cardiovascular Disease, Surgery.- Chapter 10) Acute Sarcopenia: Definition and Actual Issues.- Chapter 11) Sarcopenic Obesity.- Chapter 12) The Role of Physical Activity in Sarcopenia.- Chapter 13) Nutritional Approaches for Sarcopenia.- Chapter 14) The Future of Drugs in Sarcopenia.- Chapter 15) Sarcopenia and Covid-19: A New Entity?.